CCN2 and Alzheimer disease: The authors also found that CCN2 activated the MAPK and PI3K/Akt pathways in human H4-APP751 neuronal cells and suggested that this may lead to an increase in amyloid β peptide levels and contribute to AD pathology (Zhao et al., 2005).